Lou Barbato

Lou Barbato, MD has extensive experience in the pharmaceutical industry, with a focus on neuroscience. Lou currently serves as the Global Medical Lead for Global Medical Affairs Neuroscience at Jazz Pharmaceuticals since May 2023. Prior to this role, they were the Global Medical Lead at AbbVie from July 2015 to May 2023, where they worked on projects related to Vraylar, Multiple Sclerosis, Stroke, Spinal Cord Injury, and Parkinson's Disease. Lou also served as the Global Medical Lead at Biogen from September 2014 to July 2015, where they worked on ZINBRYTA and FAMPYRA. Before that, they held positions at Novartis, Emory University School of Medicine, Stiefel (a GSK company), Forest Laboratories (now Allergan), Tikvah Therapeutics, and Solvay Pharmaceuticals.

Lou Barbato, MD received their Bachelor of Science (BS) degree in Biology from Saint Peter's University. Lou then went on to pursue their medical education at St. George's University School of Medicine, where they obtained their Doctor of Medicine (MD) degree in Medicine. Additionally, Lou Barbato, MD attended Yale University School of Medicine, where they also earned their MD degree. The specific field of study for their MD degree at Yale University School of Medicine is not specified.